Yahoo
NYSE USD

U.S. Physical Therapy, Inc. (USPH)

85.83 -0.74 (-0.85%)
At close: October 30 at 4:00:03 PM EDT
85.83 0.00 (0.00%)
After hours: October 30 at 4:01:13 PM EDT
Trade USPH on Coinbase
Chart Range Bar
Loading chart for USPH
  • Previous Close 86.57
  • Open 87.26
  • Bid --
  • Ask 133.93 x 10000
  • Day's Range 85.19 - 87.62
  • 52 Week Range 58.19 - 90.94
  • Volume 146,352
  • Avg. Volume 179,998
  • Market Cap (intraday) 1.281B
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) 476.83
  • EPS (TTM) 0.18
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 1.84 (2.14%)
  • 1y Target Est 97.83
  • Zacks Rating Neutral

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

www.usph.com

4,653

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

USPH
12.04%
S&P 500 (^GSPC)
10.73%

1-Year Return

USPH
2.12%
S&P 500 (^GSPC)
11.11%

3-Year Return

USPH
9.43%
S&P 500 (^GSPC)
81.91%

5-Year Return

USPH
12.02%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 214.06M
Earnings 9.9M
Profit Margin 4.62%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
50M
100M
150M
200M
3.0%
4.0%
5.0%
6.0%

Analyst Insights

View More

Analyst Price Targets

95.00
97.83 Average
85.83 Current
101.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/11/2026
Analyst JP Morgan
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 90 -> 95

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.01%

  • Return on Assets (ttm)

    4.10%

  • Return on Equity (ttm)

    6.51%

  • Revenue (ttm)

    804.27M

  • Net Income Avi to Common (ttm)

    2.66M

  • Diluted EPS (ttm)

    0.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.26M

  • Total Debt/Equity (mrq)

    50.32%

  • Levered Free Cash Flow (ttm)

    41.29M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: